Published on : Mar 24, 2017
ALBANY, NY, March 24, 2017: The report presents a comprehensive outlook of the global market. It evaluates the segments present in the overall market and assesses the strengths, weaknesses, opportunities, and threats influencing these segments of the global transcatheter aortic valve replacement market. Additionally, the report also presents an examination of the drivers and restraints impacting the overall market. The publication has been compiled using primary and secondary research methodologies, thus making it an accurate and an exact in nature.
The global TAVR market is projected to grow at a steady pace in the coming years due to increasing preference for minimally-invasive surgeries. This fairly new technology has introduced a corrective treatment for the malfunctions of the heart without the need for a by-pass surgery. Several healthcare professionals and patients are opting for TAVR as it is far more feasible than the conventional surgical aortic valve replacement. Currently, it is being considered to be the best option for patients who have chances to undergoing intermediate or high risk of complications due to surgical aortic valve replacement. The growing preference to avoid open-heart surgeries is expected to augment the demand for transcatheter aortic valve replacement in the near future.
Click to get more details with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=1012263
The global market is being tremendously fueled by the rising pool of geriatrics, who are prone to a wide range of cardiovascular diseases. The increasing expenditure on healthcare, improved healthcare infrastructure, supportive reimbursement schemes, and increase base of obese population are all expected to make a significant contribution to the emergence of the TAVR market in the forecast period. Despite the strong market drivers, the market is likely to be shaken up by a few challenges. The current restraints in the global market are risk of security breaches, business cycle fluctuations, unaffordability of TAVR devices, and the risk associated with the procedure.
The improving healthcare infrastructure of developing countries is projected to offer several lucrative opportunities to the global market in the coming years. The rise of medical tourism in developing countries of Brazil and India are also likely to have a positive impact on the overall market, project analysts.
Some of the leading players operating in the global transcatheter aortic valve replacement market are Boston Scientific, Edwards Lifesciences, St. Jude Medical, Inc., and Medtronic Plc. The research report provides a thorough analysis of these players and explains the nature of the competitive landscape present in the overall market. The publication also explains the research and development strategies of these players, their business and marketing plans, and their expansion plans for the near future. With the help of a porter’s five forces analysis, the document presents a clear scenario of the intensity of the competition in the global market.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]